Dave Muoio
.jpg?itok=J7uZvAAn)
04:51 pm
March 31, 2021
Published yesterday in PLoS ONE, the data suggests an alternative to the six-minute walk test often conducted in clinics to measure functional capacity.
.jpg?itok=zVfjf3FP)
02:18 pm
March 31, 2021
The deal is valued at about $194 million and will drive about a third of the telemedicine company's expected revenue moving forward.
05:19 pm
March 10, 2021
Providers will be able to have in-app live video conversations with chronic pain and movement disorder patients, as well as prescribe new settings for their neuromodulation therapies from afar.
03:35 pm
February 26, 2021
Set to close in Q2, the deal will provide the payer's healthcare services subsidiary with an integrated virtual care offering.
03:32 pm
February 26, 2021
Industry regulatory leaders outline the best approaches for digital health companies looking to make sense of FDA's long-in-the-tooth enforcement discretion guidelines.
10:42 am
February 10, 2021
Saykara's founder and team will be augmenting Nuance's R&D division.
10:34 am
February 10, 2021
Thirty mobile health apps from larger healthcare information technology companies were susceptible to a broken object level authorization (BOLA) attack.
05:52 pm
February 05, 2021
The company hopes that its more descriptive reports will distinguish the personal ECG offering from others limited to atrial fibrillation detection alone.
05:07 pm
December 18, 2020
The tech company elaborated on its established digital health and wellness vision while improvising with the demands of an unexpected pandemic.
05:24 pm
November 19, 2020
Lucira's molecular testing kit allows individuals to collect their own nasal sample and insert it into a device that provides results in under 30 minutes. The company is aiming to sell the single-use tests for roughly $50.
